See more : Prodways Group SA (PRWYF) Income Statement Analysis – Financial Results
Complete financial analysis of The Valens Company Inc. (VLNS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Valens Company Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- CD Projekt S.A. (OTGLF) Income Statement Analysis – Financial Results
- Emclaire Financial Corp (EMCF) Income Statement Analysis – Financial Results
- Global Payment Technologies Inc. (GPTX) Income Statement Analysis – Financial Results
- PT Sarana Menara Nusantara Tbk. (SMNUF) Income Statement Analysis – Financial Results
- Ratnaveer Precision Engineering Limited (RATNAVEER.BO) Income Statement Analysis – Financial Results
The Valens Company Inc. (VLNS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.thevalenscompany.com
About The Valens Company Inc.
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles, natural health, and other products. In addition, it offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, product development, and custom manufacturing services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.
The Valens Company partners with Montreal Cannabis Médical for extraction and manufacturing of pre-rolls and vapes
The Valens Company inks two agreements with PMI Mexico, one of the leading drug suppliers to the Mexican government
Valens Company Signs Agreements With Mexican Drug Supplier To Provide CBD Oil And Prebiotic Products
Stifel GMP repeats 'Buy' on The Valens Company as it thinks "risk-reward seems appealing now"
The Valens Company secures C$40M term loan to support “aggressive growth strategy”
The Valens Company Borrows $31.3M To Retire Its Debt And Strengthen Balance Sheet
9 Hottest Stories from the Cannabis Sector This Week
Canadian cannabis company Valens debuts shares on Nasdaq
The Valens Company Shares Surge On $54.3M Citizen Stash Cannabis Acquisition
The Valens Company And Marijuana Retailer Fire & Flower Enter White Label Partnership
Source: https://incomestatements.info
Category: Stock Reports